Aurobindo, Hetero, and Vivimed Class Action Settlements in Michigan
Aurobindo, Hetero, and Vivimed class action settlements that covered Michigan residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
Michigan residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for Michigan Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in Michigan
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
Michigan residents affected by contaminated blood pressure medications from Aurobindo, Hetero, and Vivimed pharmaceutical companies have legal recourse through class action settlements. The $15.2 million Valsartan, Losartan and Irbesartan settlement specifically covers medications manufactured by these companies that contained NDMA and other carcinogenic impurities. Michigan's Consumer Protection Act provides additional protections beyond federal regulations, allowing residents to seek damages for deceptive business practices in pharmaceutical sales. These three companies distribute generic medications widely throughout Michigan's healthcare system, with Aurobindo maintaining significant market share in the state's pharmacy chains. Hetero and Vivimed products are commonly found in Michigan hospitals and retail pharmacies. Michigan residents filing class action claims must typically demonstrate they purchased or consumed the contaminated medications during specified time periods. The state's six-year statute of limitations for consumer protection claims may provide longer filing windows than other jurisdictions. Michigan's consolidated court system processes pharmaceutical class actions efficiently, often coordinating with federal multidistrict litigation proceedings for streamlined settlements.
Aurobindo, Hetero, and Vivimed Settlements in Michigan: FAQs
How does Michigan's Consumer Protection Act affect Aurobindo, Hetero, and Vivimed settlements?
Michigan's Consumer Protection Act provides additional grounds for claims beyond federal pharmaceutical regulations. Residents can pursue damages for deceptive practices if these companies failed to disclose contamination risks. This may result in higher settlement amounts for Michigan claimants compared to states with weaker consumer protection laws.
Are Aurobindo, Hetero, and Vivimed medications commonly prescribed in Michigan?
Yes, all three companies supply generic blood pressure medications widely distributed through Michigan's major pharmacy chains including Meijer, Rite Aid, and hospital systems. The $15.2 million settlement specifically covers their contaminated Valsartan, Losartan, and Irbesartan products sold throughout Michigan. Many Michigan residents likely consumed these medications without knowing about the contamination.
What's the filing deadline for Michigan residents in the Aurobindo, Hetero, and Vivimed settlement?
While the $15.2 million settlement has specific deadlines, Michigan's six-year statute of limitations for consumer protection claims may allow additional filing time. Michigan residents should check both the federal settlement deadlines and state law protections. Consulting with a Michigan attorney can clarify which timeline applies to your specific situation.
Tips for Michigan Residents Filing Aurobindo, Hetero, and Vivimed Claims
Michigan residents should gather all prescription records and pharmacy receipts showing purchases of Valsartan, Losartan, or Irbesartan from Aurobindo, Hetero, or Vivimed between affected dates. Contact your prescribing physician to document any health impacts or medication changes required due to contamination. File claims promptly within settlement deadlines, but also consider Michigan's extended consumer protection statute of limitations. Keep detailed medical records showing any adverse effects or additional monitoring required. Consider consulting Michigan attorneys familiar with both federal pharmaceutical settlements and state consumer protection law to maximize potential recovery under both frameworks.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
